Nanjing, China

Jianqiang Li

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 11.3

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: **Innovative Contributions of Inventor Jianqiang Li**

Introduction

Jianqiang Li is a renowned inventor based in Nanjing, China, recognized for his impactful innovations in the pharmaceutical industry. With a focus on hepatitis B treatments, Li has developed notable pharmaceutical preparations that contribute significantly to public health.

Latest Patents

Jianqiang Li holds two patents, showcasing his expertise and creativity in formulating groundbreaking medical solutions. His latest patents include:

1. **Pharmaceutical preparation for treating hepatitis B, preparation method therefor and use thereof** - This invention discloses a novel pharmaceutical preparation consisting of a solution of hepatitis B surface antigen, a solution of hepatitis B core antigen, and an oligodeoxynucleotide solution. It emphasizes the absence of saccharides, features a simple composition with good antigen stability, and avoids adverse reactions commonly caused by aluminum adjuvants. Notably, it exhibits excellent preservation effects in long-term stability experiments.

2. **Hepatitis B vaccine** - This patent describes a composition that includes HBsAg, a fragment or variant thereof, and HBcAg1-X along with a 21-base long CpG-ODN. The inclusion of these components aims to enhance the treatment of HBV infection and HBV-induced diseases, along with innovative therapy methods for these conditions.

Career Highlights

Jianqiang Li has made significant strides in his career, having worked with prominent companies in the bio-pharmaceutical field. He was associated with Jiangsu Theravac Bio-pharmaceutical Co., Ltd. and Grand Theravac Life Sciences (Nanjing) Co., Ltd., where he contributed to developing new therapeutic solutions.

Collaborations

Throughout his career, Jianqiang Li has collaborated with noted professionals in the field, including colleagues Jun Ge and Tong Zhou. These collaborations have facilitated a dynamic exchange of ideas, enhancing the innovative processes behind his notable inventions.

Conclusion

Jianqiang Li's contributions to pharmaceutical innovations, particularly in the treatment of hepatitis B, highlight his role as a pioneering inventor. With a commitment to advancing public health through research and development, Li’s patents represent a significant step forward in combating viral infections and improving therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…